(Q40226955)

English

Phase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in chinese healthy volunteers

scientific article published on 4 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Phase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in chinese healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Li Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Jinfang Shen

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Xiaoyun Pang

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Lungen Lu

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yimin Mao

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Minde Zeng

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

767-773

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Report of a case showing a recovery from liver cirrhosis to chronic hepatitis, type C, after glycyrrhizin injection for 2 years and a sustained response by the following interferon therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Pharmacokinetics of magnesium glycyrrhizinate following intravenous administration of magnesium glycyrrhizinate in rats

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model.

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299757

21 January 2018

Identifiers

10.1177/0091270007299757

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40226955&oldid=1889380237"